Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954108 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Phosphoglycolate Phosphatase (PGP) (AA 40-70), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 40-70, N-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines.
The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia.
Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness.
P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
GarcĂa MG, Alaniz LD, Cordo Russo RI, Alvarez E, Hajos SE
Leukemia research 2009 Feb;33(2):288-96
Leukemia research 2009 Feb;33(2):288-96
The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia.
Lin YC, Ellingrod VL, Bishop JR, Miller DD
Therapeutic drug monitoring 2006 Oct;28(5):668-72
Therapeutic drug monitoring 2006 Oct;28(5):668-72
Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6, CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness.
de Leon J, Susce MT, Pan RM, Koch WH, Wedlund PJ
Journal of clinical psychopharmacology 2005 Oct;25(5):448-56
Journal of clinical psychopharmacology 2005 Oct;25(5):448-56
P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
Turzanski J, Grundy M, Shang S, Russell N, Pallis M
Experimental hematology 2005 Jan;33(1):62-72
Experimental hematology 2005 Jan;33(1):62-72
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS